Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.880
+0.130 (7.43%)
At close: Apr 2, 2026
APUS Market Cap
APUS has a market cap or net worth of $23.64 million as of April 13, 2026.
Market Cap
23.64M
Enterprise Value
n/a
1-Year Change
n/a
Ranking
Category
Stock Price
$1.88
Market Cap Chart
Since the IPO on March 27, 2026, APUS's market cap has decreased from $24.02M to $23.64M, a decrease of -1.57%. That is a compound annual growth rate of -61.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 2, 2026 | 23.64M | 7.43% |
| Apr 1, 2026 | 22.01M | -2.20% |
| Mar 31, 2026 | 22.50M | 2.25% |
| Mar 30, 2026 | 22.01M | -8.38% |
| Mar 27, 2026 | 24.02M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cumberland Pharmaceuticals | 46.22M |
| SCYNEXIS | 44.66M |
| Incannex Healthcare | 43.60M |
| InterCure | 42.90M |
| Talphera | 38.07M |
| Rockwell Medical | 35.85M |
| BioXcel Therapeutics | 28.70M |
| Aytu BioPharma | 27.37M |